To evaluate the illumigene Chlamydia and illumigene Gonorrhea assays, using the illumipro-10, with male urine, female urine, physician-collected (medical professional) endocervical swabs and self-collected vaginal swabs taken from symptomatic and asymptomatic patient populations.
Study Type
OBSERVATIONAL
Enrollment
700
Planned Parenthood of the Rocky Mountains
Aurora, Colorado, United States
New England Center for Clinical Research
Fall River, Massachusetts, United States
Planned Parenthood Southeastern PA
Philadelphia, Pennsylvania, United States
Qualitative detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease
Testing of each set of subject samples is completed within 60 days of sample collection
Time frame: Up to 60 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.